Glasgow 2018 e-Newsletter

 

HIVGlasgow2018_eNewsletter_Banner_v1

 

HIVGLASGOW18_e-Newsletter_Button

   

About the Program:

Program Overview:

The ARV Therapies and Therapeutic Strategies program is a comprehensive, independent review of the HIV Glasgow Drug Therapy Congress (HIV Glasgow 2018). This program consists of five components: (1) CME Internet Symposium: HIV Glasgow 2018 Expert Review**: a 1.5 hour internet symposium that features an overview and discussion of key presentations and posters, selected by the expert faculty discussants; (2) European Perspective on HIV Glasgow 2018**: a 1 hour panel discussion featuring Europe-based expert faculty reviewing and discussing key presentations with a focus on clinical management and treatment in the EU; (3) Rapid-Fire Review of HIV Glasgow 2018**: a podcast that provides a brief audio summary of the most essential data presented at the conference; (4) From Conference to Clinic: Reviewing and Applying Data From HIV Glasgow 2018**: case-based dinner meetings during which the key data are reviewed, discussed, and applied to patient care and (5) HIV Glasgow 2018 e-Newsletter: a brief on-line summary of the most essential data presented at the conference.

The HIV Glasgow 2018 e-Newsletter features a portable electronic summary of key presentations and data presented at the conference. This activity will quickly enable participating health care providers caring for HIV-infected patients to become aware of and understand the data presented at this important conference and appropriately utilize those data to improve patient care.  

This program is jointly provided by the Annenberg Center for Health Sciences at Eisenhower and ViralEd, Inc. It is not a session created by or presented at HIV Glasgow 2018 and it is not sanctioned by the organizers of HIV Glasgow 2018. 

** This component is jointly provided by the Postgraduate Institute for Medicine and ViralEd, Inc and supported by an independent educational grant from Gilead Sciences Medical Affairs. 

Back to Top

Target Audience:

This activity has been designed to meet the educational needs of physicians, physician assistants, advanced practice nurses, and other health care professionals involved in the care of patients with HIV infection.

Back to Top

Learning Objectives:

After completing this activity, the participant should be better able to:

  • Review data reported at HIV Glasgow 2018 for counseling, testing and antiretroviral treatment to prevent HIV infection, especially in underserved communities 
  • Relate in a clinical setting, findings from key studies on HIV/AIDS diagnosis, management, and treatment presented at HIV Glasgow 2018 
  • Employ strategies based on studies and data presented at HIV Glasgow 2018 for helping HIV-positive patients in medically underserved communities link to and stay in appropriate and effective HIV care 
  • Discuss with patients and colleagues the studies and data on therapies for HIV/AIDS presented at HIV Glasgow 2018 and use that discussion to decide on appropriate planning of therapy for patients with HIV/AIDS 

Release Date: November 27, 2018

Expiration Date: November 27, 2019

Estimated time to complete the program: 30 minutes

Mechanism for the learner to contact PIM: www.pimed.com

Type of hardware/softward needed to participate in activity: PC/Mac/tablet/smartphone with internet browser

Back to Top

Faculty:

Renslow Sherer, MD
Professor of Medicine
Section of Infectious Diseases and Global Health
University of Chicago
Chicago, Illinois

 
Back to Top

Accreditation Statement:

This activity has been planned and implemented in accordance with the accredtation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and ViralEd, Inc. The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing education for the healthcare team. 

Credit Designation:

The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of .5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Back to Top

European Continuous Medical Education Credit:

AMA PRA Category 1 CreditsTM claimed by physicians attending live events certified and organized in the United States for AMA PRA Category 1 Credits TM can be claimed through the agreement on mutual recognition of credits between UEMS and AMA, considered as being equal to the European Continuous Medical Education Credits (ECMEC®) granted by the UEMS. One AMA PRA Category 1 CreditTM is equivalent to one (1) hour of European EACCME Credit (ECMEC®), therefore up to 1.0 ECMEC® Credits are available.

Back to Top

Disclosure of Conflicts of Interest:

The Annenberg Center for Health Sciences at Eisenhower requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to The Annenberg Center for Health Sciences at Eisenhower policy. The Annenberg Center for Health Sciences at Eisenhower is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of these CME activities:

Renslow Sherer, MD

  • Consulting Fees: Gilead

 

Charles E. Willis, Director of Continuing Education from the Annenberg Center for Health Sciences at Eisenhower consults for Pfizer, Inc.; Amanda Sewell, MBA, Manager of Continuing Education and Melissa Velasquez, Accreditation Specialist both from the Annenberg Center for Health Sciences at Eisenhower have no relevant commercial relationships to disclose.

The PIM planners and managers have nothing to disclose.

 

Back to Top

Instructions for Participation and Credit:

There are no fees for participating and received CME credit for this activity.  During the period, November 27, 2018 through November 27, 2019, participants must read the learning objectives and faculty disclosures and study the educational activity.

PIM supports Green CME by offering your Request for Credit online. If you wish to received acknowledgment of completing this activity, please complete the post-test and evaluation on http://www.cmeuniversity.com/. On the navigation menu, click on "Find Post-test/Evaluation by Course" and search by course ID 13764.  Upon registering and successfully completing the post-test with a score of 70% or better and the activity evaluation, your certificate will be made available immediately.  Processing credit requests online will reduce the amount of paper used by nearly 100,000 sheets per year.

Back to Top

Disclosure of Unlabeled Use:

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.  

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners.  Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Back to Top

Disclaimer:

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

Back to Top

 

PIM_small          Annenberg Center For Health Science logo

VE logo 300px

This activity is supported by an independent educational grant from Janssen Therapeutics.

This coverage is not sanctioned by the conference organizers and is not an official part of the conference proceedings.

 


Prepare to print

Share this page:

Get link code to this page                     


Back to Top